Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies

Wissam H Faour1, Ali Choaib2, Elio Issa2

  • 1Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, P.O. Box 36, Byblos, Lebanon. wissam.faour@lau.edu.lb.

Insights

This review details COVID-19's impact on kidney health, covering inflammatory and noninflammatory kidney issues. It examines disease mechanisms and treatments, highlighting how medications may worsen renal damage.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Pharmacology

Background:

  • The COVID-19 pandemic caused a global health crisis with significant mortality.
  • Kidney manifestations of COVID-19, both inflammatory and noninflammatory, are underrepresented in current literature.
  • Understanding these kidney issues is crucial for comprehensive patient care.

Purpose of the Study:

  • To review current knowledge on COVID-19-related kidney manifestations.
  • To explore the underlying pathologic mechanisms of these renal complications.
  • To analyze the impact of COVID-19 pharmacotherapies on kidney function.

Main Methods:

  • Systematic literature review of COVID-19 and kidney disease.
  • Analysis of pathological mechanisms linking SARS-CoV-2 infection to renal damage.
  • Evaluation of drug effects on kidney function in COVID-19 patients.

Main Results:

  • COVID-19 can cause diverse kidney problems, including acute kidney injury and glomerulopathy.
  • Viral infection and systemic inflammation contribute to kidney damage.
  • Certain medications used for COVID-19 may exacerbate pre-existing or induced renal impairment.

Conclusions:

  • COVID-19 poses a significant threat to kidney health through various mechanisms.
  • Pharmacotherapies for COVID-19 require careful consideration regarding their nephrotoxic potential.
  • Further research is needed to optimize treatment strategies and protect kidney function in COVID-19 patients.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
82
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
68
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
196
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
561
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
106
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
133